ADMA BIOLOGICS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
ADMA BIOLOGICS, INC. (ADMA) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.02 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-05
- ADMA BIOLOGICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 2.02M shares.
- ADMA BIOLOGICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 1.49M shares.
- ADMA BIOLOGICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 0.00 shares.
- ADMA BIOLOGICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 0.00 shares.
- ADMA BIOLOGICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 0.00 shares.
- ADMA BIOLOGICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 0.00 shares, a 100.00% decline from fiscal 2023.
- ADMA BIOLOGICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 23.07M shares, a 6.42% decline from fiscal 2022.
- ADMA BIOLOGICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 24.65M shares, a 46.06% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 2.02M shares 10-Q · filed 2026-08-05 | 2.02M shares 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | 1.49M shares 10-Q · filed 2026-05-06 | ||||
| 2025-12-31 | 0.00 shares 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-05 | 0.00 shares 10-Q · filed 2025-11-05 | |||
| 2025-06-30 | 0.00 shares 10-Q · filed 2026-08-05 | 0.00 shares 10-Q · filed 2026-08-05 | |||
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-06 | ||||
| 2024-12-31 | 0.00 shares 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | 0.00 shares 10-Q · filed 2025-11-05 | 0.00 shares 10-Q · filed 2025-11-05 | |||
| 2024-06-30 | 0.00 shares 10-Q · filed 2025-08-06 | 0.00 shares 10-Q · filed 2025-08-06 | |||
| 2024-03-31 | 0.00 shares 10-Q · filed 2025-05-07 | ||||
| 2023-12-31 | 23.07M shares 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | 0.00 shares 10-Q · filed 2024-11-07 | 23.22M shares 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | 26.96M shares 10-Q · filed 2024-08-08 | ||||
| 2023-03-31 | 28.35M shares 10-Q · filed 2024-05-09 | ||||
| 2022-12-31 | 24.65M shares 10-K · filed 2025-03-18 | ||||
| 2022-09-30 | 26.02M shares 10-Q · filed 2023-11-08 | ||||
| 2022-06-30 | 26.80M shares 10-Q · filed 2023-08-09 | ||||
| 2022-03-31 | 27.05M shares 10-Q · filed 2023-05-10 | ||||
| 2021-12-31 | 16.88M shares 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | 16.83M shares 10-Q · filed 2022-11-09 | ||||
| 2021-06-30 | 13.00M shares 10-Q · filed 2022-08-10 | ||||
| 2021-03-31 | 13.36M shares 10-Q · filed 2022-05-11 | ||||
| 2020-12-31 | 11.78M shares 10-K · filed 2022-03-24 | ||||
| 2020-09-30 | 9.41M shares 10-Q · filed 2021-11-10 | ||||
| 2020-06-30 | 9.27M shares 10-Q · filed 2021-08-11 | ||||
| 2020-03-31 | 9.23M shares 10-Q · filed 2021-05-12 | ||||
| 2019-12-31 | 7.77M shares 10-K · filed 2021-03-25 | ||||
| 2019-09-30 | 7.78M shares 10-Q · filed 2020-11-05 | ||||
| 2019-06-30 | 7.76M shares 10-Q · filed 2020-08-05 | ||||
| 2019-03-31 | 7.49M shares 10-Q · filed 2020-05-06 | ||||
| 2018-12-31 | 4.87M shares 10-K · filed 2020-03-13 | ||||
| 2018-09-30 | 4.81M shares 10-Q · filed 2019-11-06 | ||||
| 2018-06-30 | 4.78M shares 10-Q · filed 2019-08-08 | ||||
| 2018-03-31 | 4.66M shares 10-Q · filed 2019-05-08 | ||||
| 2017-12-31 | 3.80M shares 10-K · filed 2019-03-13 | ||||
| 2017-09-30 | 3.47M shares 10-Q · filed 2018-11-09 | ||||
| 2017-06-30 | 3.51M shares 10-Q · filed 2018-08-10 | 3.50M shares 10-Q · filed 2017-08-11 | |||
| 2017-03-31 | 1.88M shares 10-Q · filed 2018-05-14 | ||||
| 2016-12-31 | 1.84M shares 10-K · filed 2018-03-29 | ||||
| 2016-09-30 | 1.84M shares 10-Q · filed 2017-11-03 | ||||
| 2016-06-30 | 1.80M shares 10-Q · filed 2017-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |